Insider · CIK 0001203324
Howard T Slayen
director
Files at AEHR (AEHR TEST SYSTEMS). First filing Nov 5, 2025, latest Nov 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $154k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AEHR: AEHR TEST SYSTEMS
AEHROct 9, 2026 · close 84.64
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | AEHRsell AEHR TEST SYSTEMS | $154k 6,000 shares | -3% | +280% from low-23% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -5,000 | $0.00 | $0 | 213,328 | Feb 4, 2026 |
| Feb 4, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -5,000 | $0.00 | $0 | 208,328 | Feb 4, 2026 |
| Feb 4, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -5,000 | $0.00 | $0 | 203,328 | Feb 4, 2026 |
| Nov 5, 2025 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stock | -6,000 | $25.73 | $154k | 218,328 | Nov 5, 2025 |
| Sep 24, 2025 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -5,000 | $0.00 | $0 | 224,328 | Sep 25, 2025 |
| Sep 2, 2025 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -639 | $0.00 | $0 | 229,328 | Sep 2, 2025 |
| Jul 2, 2025 | AEHR AEHR TEST SYSTEMS | AGrant or award Common Stock | +9,253 | $0.00 | $0 | 229,967 | Jul 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.